All In Biotech

Drug Trial Radar · NCT06656416

ALTO-100 in Bipolar Disorder With Depression (BD-D)

A Randomized, Double-Blind, Placebo-Controlled Study Followed by Open-Label Treatment of ALTO-100 in Adults With Bipolar Disorder Currently Experiencing a Major Depressive Episode

Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Oct 2, 2024

Primary completion

Sep 2027

Study completion Oct 2027

Sponsor

Lead sponsor
Alto NeuroscienceIndustry
Sponsor type
Industry
First posted
Oct 24, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess antidepressant efficacy differences between ALTO-100 and placebo during the Double-Blind period in patients with bipolar disorder I or II with current major depressive episode, when used adjunctively to a mood stabilizer and/or atypical antipsychotic, related to patient characteristics. Additionally, safety, tolerability, and efficacy will be assessed in a subsequent open label treatment period.

Conditions

  • Bipolar Disorder I or II With a Major Depressive Episode

Interventions

  • ALTO-100Drug

    ALTO-100 40 mg tablet BID

  • PlaceboDrug

    Placebo tablet BID

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess efficacy of ALTO-100 versus placebo on depression symptoms in bipolar disorder in a pre-defined subgroup of participants as measured by the mean change from Day 1 to Week 6 on the Montgomery-Åsberg Depression Rating Scale (MADRS) total scoreTime frame: Change assessed from Day 1 to Week 6

Locations

68 sites in 2 countries. Site status is shown where the registry gives one.

  • Site 6074

    Birmingham, Alabama · Withdrawn

  • Site 6036

    Chandler, Arizona · Withdrawn

  • Site 6000

    Phoenix, Arizona · Recruiting

  • Site 6087

    Yuma, Arizona · Withdrawn

  • 6039

    Fayetteville, Arkansas · Withdrawn

  • 6070

    Little Rock, Arkansas · Terminated

  • Site 6133

    Little Rock, Arkansas · Recruiting

  • Site 6153

    Chino, California · Recruiting

  • Site 6081

    Imperial, California · Withdrawn

  • 6069

    Los Angeles, California · Recruiting

  • Site 6016

    Mather, California · Recruiting

  • Site 6082

    Oceanside, California · Terminated

  • Site 6102

    Riverside, California · Withdrawn

  • Site 6111

    Sacramento, California · Recruiting

  • Site 6120

    San Jose, California · Recruiting

  • Site 6112

    Colorado Springs, Colorado · Recruiting

  • Site 6174

    Jacksonville, Florida · Recruiting

  • Site 6067

    Lauderhill, Florida · Withdrawn

  • Site 6123

    Pinellas Park, Florida · Recruiting

  • Site 6015

    Tampa, Florida · Recruiting

  • Site 6193

    Atlanta, Georgia · Not yet recruiting

  • Site 6068

    Atlanta, Georgia · Withdrawn

  • Site 6064

    Peachtree Corners, Georgia · Recruiting

  • Site 6113

    Chicago, Illinois · Recruiting

  • Site 6132

    Carmel, Indiana · Recruiting

  • Site 6101

    West Lafayette, Indiana · Terminated

  • Site 6151

    Baltimore, Maryland · Withdrawn

  • Site 6076

    Bel Air, Maryland · Recruiting

  • Site 6062

    Gaithersburg, Maryland · Recruiting

  • Site 6182

    Towson, Maryland · Recruiting

  • Site 6188

    Worcester, Massachusetts · Recruiting

  • Site 6184

    Ann Arbor, Michigan · Recruiting

  • Site 6155

    Ann Arbor, Michigan · Recruiting

  • Site 6178

    Grand Rapids, Michigan · Recruiting

  • Site 6122

    Flowood, Mississippi · Recruiting

  • Site 6142

    Lincoln, Nebraska · Withdrawn

  • Site 6144

    Las Vegas, Nevada · Recruiting

  • Site 6104

    Las Vegas, Nevada · Recruiting

  • Site 6066

    Toms River, New Jersey · Recruiting

  • Site 6014

    Albuquerque, New Mexico · Recruiting

Showing 40 of 68 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.